Jul 13, 2022 / 09:00PM GMT
Operator
Ladies and gentlemen, good afternoon, and welcome to the Theravance Biopharma Conference Call. At this time, I would like to inform you that this call is being recorded. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the Company's formal remarks. (Operator Instructions). And now I would like to turn the call over to Gail Cohen, Corporate Communications. Please go ahead.
Gail Cohen - Theravance Biopharma - Corporate Communications & IR
Good afternoon, everyone, and thank you for joining us on the call today. As always, I remind you that portions of the following discussion, including responses to questions, contain statements that relate to future events and performance rather than historical facts and constitute forward looking statements. Our actual results might differ materially from those projected in these forward looking statements.
Additional information concerning factors that could cause results to differ materially form our forward-looking statements is described further
Theravance Biopharma Inc to Sell Trelegy Ellipta Royalty Interests to Royalty Pharma - Conference Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers